Puma Biotechnology (PBYI) Retained Earnings (2010 - 2026)

Puma Biotechnology (PBYI) has 17 years of Retained Earnings data on file, last reported at -$31000.0 in Q1 2026.

• Quarterly Retained Earnings rose 100.0% year-over-year to -$31000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31000.0 (up 100.0% YoY) and the FY2025 annual result came in at $36000.0, up 100.0% from the prior year.
• Retained Earnings declined to -$31000.0 in Q1 2026, from $36000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $36000.0 in Q4 2025 to a low of -$1.4 billion in Q1 2022.
• A 5-year average of -$894.7 million and a median of -$1.3 billion in 2024 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings plunged 136078800.0% — and 2025, when it jumped 100.0%.
• Tracing PBYI's Retained Earnings over 5 years: stood at -$1.4 billion in 2022, then gained by 1.15% to -$1.3 billion in 2023, then gained by 2.25% to -$1.3 billion in 2024, then jumped by 100.0% to $36000.0 in 2025, then sank by 186.11% to -$31000.0 in 2026.
• The last three Retained Earnings figures came in at -$31000.0 (Q1 2026), $36000.0 (Q4 2025), and $19000.0 (Q3 2025), per Business Quant data.